Related Experiment Video

Updated: Jun 2, 2026

Retinal Organoid Induction System for Derivation of 3D Retinal Tissues from Human Pluripotent Stem Cells
10:05

Retinal Organoid Induction System for Derivation of 3D Retinal Tissues from Human Pluripotent Stem Cells

Published on: April 12, 2021

Pluripotent human stem cells for the treatment of retinal disease

Teisha J Rowland1, David E Buchholz, Dennis O Clegg

  • 1Center for Stem Cell Biology and Engineering, University of California, Santa Barbara, California, USA.

Journal of Cellular Physiology
|April 27, 2011
PubMed

Insights

Stem cell therapies offer new hope for retinal diseases like age-related macular degeneration. Research is advancing the use of human stem cells to replace damaged retinal cells, improving treatment potential.

Area of Science:

  • Ophthalmology
  • Regenerative Medicine
  • Stem Cell Biology

Background:

  • Limited therapeutic options exist for debilitating retinal diseases.
  • Significant advancements in understanding ocular biology have been made.
  • Stem cell-based therapies present a promising treatment avenue.

Purpose of the Study:

  • To review current research in stem cell-based therapies for retinal diseases.
  • To evaluate different types of human stem cells for ocular cell differentiation.
  • To assess protocols for cell differentiation, culture, and transplantation.

Main Methods:

  • Review of current scientific literature on stem cell therapies for retinal diseases.
  • Evaluation of pluripotent stem cells, including human embryonic stem cells and induced pluripotent stem cells.
  • Analysis of differentiation protocols for ocular cells and transplantation techniques.

Main Results:

  • Various human stem cell types show potential for differentiating into retinal pigmented epithelium and photoreceptors.
  • Significant progress has been made over the last decade in stem cell research for retinal applications.
  • Differentiation, culture, and transplantation techniques are under development for clinical use.

Conclusions:

  • Stem cell therapies are a viable strategy for treating retinal diseases such as age-related macular degeneration, Stargardt's macular dystrophy, and retinitis pigmentosa.
  • Further development of differentiation and transplantation protocols is crucial for successful clinical application.
  • Human pluripotent stem cells offer a promising source for regenerative treatments in ophthalmology.

More Related Videos

Efficient Derivation of Retinal Pigment Epithelium Cells from Stem Cells07:07

Efficient Derivation of Retinal Pigment Epithelium Cells from Stem Cells

Published on: March 8, 2015

Generating Neural Retina from Human Pluripotent Stem Cells05:03

Generating Neural Retina from Human Pluripotent Stem Cells

Published on: December 22, 2023

Related Concept Videos

Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.